CLINICAL_TRIALS
trial_result
· 2021-03-26
Clinical Trial Update: The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome [Phase 2]
Summary
Phase 2 trial assessing how an antibiotic impacts production of uremic toxins by the gut microbiome in end-stage renal disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: NYU Langone Health | Conditions: End Stage Renal Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-03-26